Efficacy and safety of onabotulinumtoxinA in pediatric patients with chronic migraine

被引：0
|
作者：
Caronna, E. [1 ]
Mas-de-les-Valls-Cerco, R. [1 ]
Gallardo, V. J. [1 ]
Gomez-Dabo, L. [1 ]
Alpuente, A. [1 ]
Torres-Ferrus, M. [1 ]
Pozo-Rosich, P. [1 ]
机构：
[1] Univ Autonoma Barcelona, Vall dHebron Hosp & Res Inst, Dept Neurol, Headache Clin, Barcelona, Spain
来源：
JOURNAL OF HEADACHE AND PAIN | 2024年 / 25卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
P158
引用
收藏
页数：2
相关论文
共 50 条
  • [11] Efficacy and Safety of OnabotulinumtoxinA in an Open-Label Study for the Prophylactic Treatment of Chronic Migraine in Adult Patients: COMPEL
    Blumenfeld, Andrew
    Stark, Richard
    Adams, Aubrey Manack
    Orejudos, Amelia
    Aurora, Sheena
    NEUROLOGY, 2017, 88
  • [12] Effectiveness and safety of OnabotulinumtoxinA in the treatment of chronic migraine in patients older than 65
    Castanon, M.
    Ameijide, E.
    Sanchez, J. M.
    JOURNAL OF HEADACHE AND PAIN, 2018, 19
  • [13] Safety of Using OnabotulinumtoxinA for the Treatment of Chronic Migraine in Pregnancy
    Summers, J. E.
    Bedrin, K. O.
    Ailani, J.
    Dougherty, C. O.
    HEADACHE, 2020, 60 : 24 - 25
  • [14] OnabotulinumtoxinA for the prophylactic treatment of headaches in adult patients with chronic migraine: a safety evaluation
    Cheng, Fan
    Ahmed, Fayyaz
    EXPERT OPINION ON DRUG SAFETY, 2021, 20 (11) : 1275 - 1289
  • [15] The Long-Term Efficacy and Safety of OnabotulinumtoxinA for the Prevention of Chronic Migraine in Patients with Medication Overuse: Results of the COMPEL Study
    Tepper, S. J.
    Wilson, M.
    Orejudos, A.
    Adams, Manack A.
    Blumenfeld, A.
    HEADACHE, 2018, 58 : 93 - 94
  • [16] Long-term study of the efficacy and safety of OnabotulinumtoxinA for the prevention of chronic migraine: COMPEL study
    Blumenfeld, Andrew M.
    Stark, Richard J.
    Freeman, Marshall C.
    Orejudos, Amelia
    Adams, Aubrey Manack
    JOURNAL OF HEADACHE AND PAIN, 2018, 19
  • [17] The long-term efficacy and safety of OnabotulinumtoxinA for the prevention of chronic migraine in patients with medication overuse: results of the COMPEL study
    Tepper, S.
    Wilson, M. -C.
    Orejudos, A.
    Adams, A. Manack
    Blumenfeld, A.
    EUROPEAN JOURNAL OF NEUROLOGY, 2018, 25 : 78 - 78
  • [18] Long-term study of the efficacy and safety of OnabotulinumtoxinA for the prevention of chronic migraine: COMPEL study
    Andrew M. Blumenfeld
    Richard J. Stark
    Marshall C. Freeman
    Amelia Orejudos
    Aubrey Manack Adams
    The Journal of Headache and Pain, 2018, 19
  • [19] Efficacy, tolerability, and safety of onabotulinumtoxinA treatment for chronic migraine in patients with acute medication overuse: analysis of the PREEMPT and COMPEL trials
    Agosti, R.
    Straube, A.
    Diener, H. C.
    Freeman, M.
    Pascual Gomez, J.
    Seminerio, M.
    Delahaye, L.
    Stark, R. J.
    JOURNAL OF HEADACHE AND PAIN, 2024, 25
  • [20] Onabotulinumtoxina in chronic migraine
    Dikmen, P. Yalinay
    Aydinlar, E. Ilgaz
    Kocaman, A. Sagduyu
    CEPHALALGIA, 2015, 35 : 42 - 42
12345